Global Cephalosporin Intermediates Market Growth 2022-2028
The global market for Cephalosporin Intermediates is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Cephalosporin Intermediates market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Cephalosporin Intermediates market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Cephalosporin Intermediates market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Cephalosporin Intermediates market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Cephalosporin Intermediates players cover Antibioticos S.P.A., Biochemie, DSM, CordenPharma and Dragon Phama, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Cephalosporin Intermediates market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Cephalosporin Intermediates market, with both quantitative and qualitative data, to help readers understand how the Cephalosporin Intermediates market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Cephalosporin Intermediates market and forecasts the market size by Type (7-ACA, D-7ACA and 7-ADCA), by Application (Ceftazidime, Ceftriaxone, Cefalexin and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
7-ACA
D-7ACA
7-ADCA
Segmentation by application
Ceftazidime
Ceftriaxone
Cefalexin
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Antibioticos S.P.A.
Biochemie
DSM
CordenPharma
Dragon Phama
Nectar Lifesciences
CSPC Pharmaceutical Group
Yili Chuanning Biotechnology
Joincare Pharmaceutical Group
Jiangsu Weiqida Pharmaceutical
North China Pharmaceutical
Shanghai Shyndec Pharmaceuti
Chapter Introduction
Chapter 1: Scope of Cephalosporin Intermediates, Research Methodology, etc.
Chapter 2: Executive Summary, global Cephalosporin Intermediates market size (sales and revenue) and CAGR, Cephalosporin Intermediates market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Cephalosporin Intermediates sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Cephalosporin Intermediates sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Cephalosporin Intermediates market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Antibioticos S.P.A., Biochemie, DSM, CordenPharma, Dragon Phama, Nectar Lifesciences, CSPC Pharmaceutical Group, Yili Chuanning Biotechnology and Joincare Pharmaceutical Group, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cephalosporin Intermediates Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cephalosporin Intermediates by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cephalosporin Intermediates by Country/Region, 2017, 2022 & 2028
2.2 Cephalosporin Intermediates Segment by Type
2.2.1 7-ACA
2.2.2 D-7ACA
2.2.3 7-ADCA
2.3 Cephalosporin Intermediates Sales by Type
2.3.1 Global Cephalosporin Intermediates Sales Market Share by Type (2017-2022)
2.3.2 Global Cephalosporin Intermediates Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cephalosporin Intermediates Sale Price by Type (2017-2022)
2.4 Cephalosporin Intermediates Segment by Application
2.4.1 Ceftazidime
2.4.2 Ceftriaxone
2.4.3 Cefalexin
2.4.4 Others
2.5 Cephalosporin Intermediates Sales by Application
2.5.1 Global Cephalosporin Intermediates Sale Market Share by Application (2017-2022)
2.5.2 Global Cephalosporin Intermediates Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cephalosporin Intermediates Sale Price by Application (2017-2022)
3 Global Cephalosporin Intermediates by Company
3.1 Global Cephalosporin Intermediates Breakdown Data by Company
3.1.1 Global Cephalosporin Intermediates Annual Sales by Company (2020-2022)
3.1.2 Global Cephalosporin Intermediates Sales Market Share by Company (2020-2022)
3.2 Global Cephalosporin Intermediates Annual Revenue by Company (2020-2022)
3.2.1 Global Cephalosporin Intermediates Revenue by Company (2020-2022)
3.2.2 Global Cephalosporin Intermediates Revenue Market Share by Company (2020-2022)
3.3 Global Cephalosporin Intermediates Sale Price by Company
3.4 Key Manufacturers Cephalosporin Intermediates Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cephalosporin Intermediates Product Location Distribution
3.4.2 Players Cephalosporin Intermediates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cephalosporin Intermediates by Geographic Region
4.1 World Historic Cephalosporin Intermediates Market Size by Geographic Region (2017-2022)
4.1.1 Global Cephalosporin Intermediates Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cephalosporin Intermediates Annual Revenue by Geographic Region
4.2 World Historic Cephalosporin Intermediates Market Size by Country/Region (2017-2022)
4.2.1 Global Cephalosporin Intermediates Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cephalosporin Intermediates Annual Revenue by Country/Region
4.3 Americas Cephalosporin Intermediates Sales Growth
4.4 APAC Cephalosporin Intermediates Sales Growth
4.5 Europe Cephalosporin Intermediates Sales Growth
4.6 Middle East & Africa Cephalosporin Intermediates Sales Growth
5 Americas
5.1 Americas Cephalosporin Intermediates Sales by Country
5.1.1 Americas Cephalosporin Intermediates Sales by Country (2017-2022)
5.1.2 Americas Cephalosporin Intermediates Revenue by Country (2017-2022)
5.2 Americas Cephalosporin Intermediates Sales by Type
5.3 Americas Cephalosporin Intermediates Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cephalosporin Intermediates Sales by Region
6.1.1 APAC Cephalosporin Intermediates Sales by Region (2017-2022)
6.1.2 APAC Cephalosporin Intermediates Revenue by Region (2017-2022)
6.2 APAC Cephalosporin Intermediates Sales by Type
6.3 APAC Cephalosporin Intermediates Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cephalosporin Intermediates by Country
7.1.1 Europe Cephalosporin Intermediates Sales by Country (2017-2022)
7.1.2 Europe Cephalosporin Intermediates Revenue by Country (2017-2022)
7.2 Europe Cephalosporin Intermediates Sales by Type
7.3 Europe Cephalosporin Intermediates Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cephalosporin Intermediates by Country
8.1.1 Middle East & Africa Cephalosporin Intermediates Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cephalosporin Intermediates Revenue by Country (2017-2022)
8.2 Middle East & Africa Cephalosporin Intermediates Sales by Type
8.3 Middle East & Africa Cephalosporin Intermediates Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cephalosporin Intermediates
10.3 Manufacturing Process Analysis of Cephalosporin Intermediates
10.4 Industry Chain Structure of Cephalosporin Intermediates
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cephalosporin Intermediates Distributors
11.3 Cephalosporin Intermediates Customer
12 World Forecast Review for Cephalosporin Intermediates by Geographic Region
12.1 Global Cephalosporin Intermediates Market Size Forecast by Region
12.1.1 Global Cephalosporin Intermediates Forecast by Region (2023-2028)
12.1.2 Global Cephalosporin Intermediates Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cephalosporin Intermediates Forecast by Type
12.7 Global Cephalosporin Intermediates Forecast by Application
13 Key Players Analysis
13.1 Antibioticos S.P.A.
13.1.1 Antibioticos S.P.A. Company Information
13.1.2 Antibioticos S.P.A. Cephalosporin Intermediates Product Offered
13.1.3 Antibioticos S.P.A. Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Antibioticos S.P.A. Main Business Overview
13.1.5 Antibioticos S.P.A. Latest Developments
13.2 Biochemie
13.2.1 Biochemie Company Information
13.2.2 Biochemie Cephalosporin Intermediates Product Offered
13.2.3 Biochemie Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Biochemie Main Business Overview
13.2.5 Biochemie Latest Developments
13.3 DSM
13.3.1 DSM Company Information
13.3.2 DSM Cephalosporin Intermediates Product Offered
13.3.3 DSM Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 DSM Main Business Overview
13.3.5 DSM Latest Developments
13.4 CordenPharma
13.4.1 CordenPharma Company Information
13.4.2 CordenPharma Cephalosporin Intermediates Product Offered
13.4.3 CordenPharma Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 CordenPharma Main Business Overview
13.4.5 CordenPharma Latest Developments
13.5 Dragon Phama
13.5.1 Dragon Phama Company Information
13.5.2 Dragon Phama Cephalosporin Intermediates Product Offered
13.5.3 Dragon Phama Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Dragon Phama Main Business Overview
13.5.5 Dragon Phama Latest Developments
13.6 Nectar Lifesciences
13.6.1 Nectar Lifesciences Company Information
13.6.2 Nectar Lifesciences Cephalosporin Intermediates Product Offered
13.6.3 Nectar Lifesciences Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nectar Lifesciences Main Business Overview
13.6.5 Nectar Lifesciences Latest Developments
13.7 CSPC Pharmaceutical Group
13.7.1 CSPC Pharmaceutical Group Company Information
13.7.2 CSPC Pharmaceutical Group Cephalosporin Intermediates Product Offered
13.7.3 CSPC Pharmaceutical Group Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CSPC Pharmaceutical Group Main Business Overview
13.7.5 CSPC Pharmaceutical Group Latest Developments
13.8 Yili Chuanning Biotechnology
13.8.1 Yili Chuanning Biotechnology Company Information
13.8.2 Yili Chuanning Biotechnology Cephalosporin Intermediates Product Offered
13.8.3 Yili Chuanning Biotechnology Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Yili Chuanning Biotechnology Main Business Overview
13.8.5 Yili Chuanning Biotechnology Latest Developments
13.9 Joincare Pharmaceutical Group
13.9.1 Joincare Pharmaceutical Group Company Information
13.9.2 Joincare Pharmaceutical Group Cephalosporin Intermediates Product Offered
13.9.3 Joincare Pharmaceutical Group Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Joincare Pharmaceutical Group Main Business Overview
13.9.5 Joincare Pharmaceutical Group Latest Developments
13.10 Jiangsu Weiqida Pharmaceutical
13.10.1 Jiangsu Weiqida Pharmaceutical Company Information
13.10.2 Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Product Offered
13.10.3 Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jiangsu Weiqida Pharmaceutical Main Business Overview
13.10.5 Jiangsu Weiqida Pharmaceutical Latest Developments
13.11 North China Pharmaceutical
13.11.1 North China Pharmaceutical Company Information
13.11.2 North China Pharmaceutical Cephalosporin Intermediates Product Offered
13.11.3 North China Pharmaceutical Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 North China Pharmaceutical Main Business Overview
13.11.5 North China Pharmaceutical Latest Developments
13.12 Shanghai Shyndec Pharmaceuti
13.12.1 Shanghai Shyndec Pharmaceuti Company Information
13.12.2 Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Product Offered
13.12.3 Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Shanghai Shyndec Pharmaceuti Main Business Overview
13.12.5 Shanghai Shyndec Pharmaceuti Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Cephalosporin Intermediates Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cephalosporin Intermediates Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 7-ACA
Table 4. Major Players of D-7ACA
Table 5. Major Players of 7-ADCA
Table 6. Global Cephalosporin Intermediates Sales by Type (2017-2022) & (K Units)
Table 7. Global Cephalosporin Intermediates Sales Market Share by Type (2017-2022)
Table 8. Global Cephalosporin Intermediates Revenue by Type (2017-2022) & ($ million)
Table 9. Global Cephalosporin Intermediates Revenue Market Share by Type (2017-2022)
Table 10. Global Cephalosporin Intermediates Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Cephalosporin Intermediates Sales by Application (2017-2022) & (K Units)
Table 12. Global Cephalosporin Intermediates Sales Market Share by Application (2017-2022)
Table 13. Global Cephalosporin Intermediates Revenue by Application (2017-2022)
Table 14. Global Cephalosporin Intermediates Revenue Market Share by Application (2017-2022)
Table 15. Global Cephalosporin Intermediates Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Cephalosporin Intermediates Sales by Company (2020-2022) & (K Units)
Table 17. Global Cephalosporin Intermediates Sales Market Share by Company (2020-2022)
Table 18. Global Cephalosporin Intermediates Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Cephalosporin Intermediates Revenue Market Share by Company (2020-2022)
Table 20. Global Cephalosporin Intermediates Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Cephalosporin Intermediates Producing Area Distribution and Sales Area
Table 22. Players Cephalosporin Intermediates Products Offered
Table 23. Cephalosporin Intermediates Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cephalosporin Intermediates Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Cephalosporin Intermediates Sales Market Share Geographic Region (2017-2022)
Table 28. Global Cephalosporin Intermediates Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Cephalosporin Intermediates Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Cephalosporin Intermediates Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Cephalosporin Intermediates Sales Market Share by Country/Region (2017-2022)
Table 32. Global Cephalosporin Intermediates Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Cephalosporin Intermediates Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Cephalosporin Intermediates Sales by Country (2017-2022) & (K Units)
Table 35. Americas Cephalosporin Intermediates Sales Market Share by Country (2017-2022)
Table 36. Americas Cephalosporin Intermediates Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Cephalosporin Intermediates Revenue Market Share by Country (2017-2022)
Table 38. Americas Cephalosporin Intermediates Sales by Type (2017-2022) & (K Units)
Table 39. Americas Cephalosporin Intermediates Sales Market Share by Type (2017-2022)
Table 40. Americas Cephalosporin Intermediates Sales by Application (2017-2022) & (K Units)
Table 41. Americas Cephalosporin Intermediates Sales Market Share by Application (2017-2022)
Table 42. APAC Cephalosporin Intermediates Sales by Region (2017-2022) & (K Units)
Table 43. APAC Cephalosporin Intermediates Sales Market Share by Region (2017-2022)
Table 44. APAC Cephalosporin Intermediates Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Cephalosporin Intermediates Revenue Market Share by Region (2017-2022)
Table 46. APAC Cephalosporin Intermediates Sales by Type (2017-2022) & (K Units)
Table 47. APAC Cephalosporin Intermediates Sales Market Share by Type (2017-2022)
Table 48. APAC Cephalosporin Intermediates Sales by Application (2017-2022) & (K Units)
Table 49. APAC Cephalosporin Intermediates Sales Market Share by Application (2017-2022)
Table 50. Europe Cephalosporin Intermediates Sales by Country (2017-2022) & (K Units)
Table 51. Europe Cephalosporin Intermediates Sales Market Share by Country (2017-2022)
Table 52. Europe Cephalosporin Intermediates Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Cephalosporin Intermediates Revenue Market Share by Country (2017-2022)
Table 54. Europe Cephalosporin Intermediates Sales by Type (2017-2022) & (K Units)
Table 55. Europe Cephalosporin Intermediates Sales Market Share by Type (2017-2022)
Table 56. Europe Cephalosporin Intermediates Sales by Application (2017-2022) & (K Units)
Table 57. Europe Cephalosporin Intermediates Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Cephalosporin Intermediates Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Cephalosporin Intermediates Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Cephalosporin Intermediates Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Cephalosporin Intermediates Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Cephalosporin Intermediates Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Cephalosporin Intermediates Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Cephalosporin Intermediates Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Cephalosporin Intermediates Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Cephalosporin Intermediates
Table 67. Key Market Challenges & Risks of Cephalosporin Intermediates
Table 68. Key Industry Trends of Cephalosporin Intermediates
Table 69. Cephalosporin Intermediates Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Cephalosporin Intermediates Distributors List
Table 72. Cephalosporin Intermediates Customer List
Table 73. Global Cephalosporin Intermediates Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Cephalosporin Intermediates Sales Market Forecast by Region
Table 75. Global Cephalosporin Intermediates Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Cephalosporin Intermediates Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Cephalosporin Intermediates Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Cephalosporin Intermediates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Cephalosporin Intermediates Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Cephalosporin Intermediates Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Cephalosporin Intermediates Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Cephalosporin Intermediates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Cephalosporin Intermediates Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Cephalosporin Intermediates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Cephalosporin Intermediates Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Cephalosporin Intermediates Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Cephalosporin Intermediates Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Cephalosporin Intermediates Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Cephalosporin Intermediates Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Cephalosporin Intermediates Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Cephalosporin Intermediates Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Cephalosporin Intermediates Revenue Market Share Forecast by Application (2023-2028)
Table 93. Antibioticos S.P.A. Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 94. Antibioticos S.P.A. Cephalosporin Intermediates Product Offered
Table 95. Antibioticos S.P.A. Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Antibioticos S.P.A. Main Business
Table 97. Antibioticos S.P.A. Latest Developments
Table 98. Biochemie Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 99. Biochemie Cephalosporin Intermediates Product Offered
Table 100. Biochemie Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Biochemie Main Business
Table 102. Biochemie Latest Developments
Table 103. DSM Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 104. DSM Cephalosporin Intermediates Product Offered
Table 105. DSM Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. DSM Main Business
Table 107. DSM Latest Developments
Table 108. CordenPharma Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 109. CordenPharma Cephalosporin Intermediates Product Offered
Table 110. CordenPharma Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. CordenPharma Main Business
Table 112. CordenPharma Latest Developments
Table 113. Dragon Phama Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 114. Dragon Phama Cephalosporin Intermediates Product Offered
Table 115. Dragon Phama Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Dragon Phama Main Business
Table 117. Dragon Phama Latest Developments
Table 118. Nectar Lifesciences Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 119. Nectar Lifesciences Cephalosporin Intermediates Product Offered
Table 120. Nectar Lifesciences Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Nectar Lifesciences Main Business
Table 122. Nectar Lifesciences Latest Developments
Table 123. CSPC Pharmaceutical Group Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 124. CSPC Pharmaceutical Group Cephalosporin Intermediates Product Offered
Table 125. CSPC Pharmaceutical Group Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. CSPC Pharmaceutical Group Main Business
Table 127. CSPC Pharmaceutical Group Latest Developments
Table 128. Yili Chuanning Biotechnology Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 129. Yili Chuanning Biotechnology Cephalosporin Intermediates Product Offered
Table 130. Yili Chuanning Biotechnology Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Yili Chuanning Biotechnology Main Business
Table 132. Yili Chuanning Biotechnology Latest Developments
Table 133. Joincare Pharmaceutical Group Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 134. Joincare Pharmaceutical Group Cephalosporin Intermediates Product Offered
Table 135. Joincare Pharmaceutical Group Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Joincare Pharmaceutical Group Main Business
Table 137. Joincare Pharmaceutical Group Latest Developments
Table 138. Jiangsu Weiqida Pharmaceutical Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 139. Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Product Offered
Table 140. Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Jiangsu Weiqida Pharmaceutical Main Business
Table 142. Jiangsu Weiqida Pharmaceutical Latest Developments
Table 143. North China Pharmaceutical Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 144. North China Pharmaceutical Cephalosporin Intermediates Product Offered
Table 145. North China Pharmaceutical Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. North China Pharmaceutical Main Business
Table 147. North China Pharmaceutical Latest Developments
Table 148. Shanghai Shyndec Pharmaceuti Basic Information, Cephalosporin Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Product Offered
Table 150. Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Shanghai Shyndec Pharmaceuti Main Business
Table 152. Shanghai Shyndec Pharmaceuti Latest Developments
List of Figures
Figure 1. Picture of Cephalosporin Intermediates
Figure 2. Cephalosporin Intermediates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cephalosporin Intermediates Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cephalosporin Intermediates Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cephalosporin Intermediates Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 7-ACA
Figure 10. Product Picture of D-7ACA
Figure 11. Product Picture of 7-ADCA
Figure 12. Global Cephalosporin Intermediates Sales Market Share by Type in 2021
Figure 13. Global Cephalosporin Intermediates Revenue Market Share by Type (2017-2022)
Figure 14. Cephalosporin Intermediates Consumed in Ceftazidime
Figure 15. Global Cephalosporin Intermediates Market: Ceftazidime (2017-2022) & (K Units)
Figure 16. Cephalosporin Intermediates Consumed in Ceftriaxone
Figure 17. Global Cephalosporin Intermediates Market: Ceftriaxone (2017-2022) & (K Units)
Figure 18. Cephalosporin Intermediates Consumed in Cefalexin
Figure 19. Global Cephalosporin Intermediates Market: Cefalexin (2017-2022) & (K Units)
Figure 20. Cephalosporin Intermediates Consumed in Others
Figure 21. Global Cephalosporin Intermediates Market: Others (2017-2022) & (K Units)
Figure 22. Global Cephalosporin Intermediates Sales Market Share by Application (2017-2022)
Figure 23. Global Cephalosporin Intermediates Revenue Market Share by Application in 2021
Figure 24. Cephalosporin Intermediates Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Cephalosporin Intermediates Revenue Market Share by Company in 2021
Figure 26. Global Cephalosporin Intermediates Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Cephalosporin Intermediates Revenue Market Share by Geographic Region in 2021
Figure 28. Global Cephalosporin Intermediates Sales Market Share by Region (2017-2022)
Figure 29. Global Cephalosporin Intermediates Revenue Market Share by Country/Region in 2021
Figure 30. Americas Cephalosporin Intermediates Sales 2017-2022 (K Units)
Figure 31. Americas Cephalosporin Intermediates Revenue 2017-2022 ($ Millions)
Figure 32. APAC Cephalosporin Intermediates Sales 2017-2022 (K Units)
Figure 33. APAC Cephalosporin Intermediates Revenue 2017-2022 ($ Millions)
Figure 34. Europe Cephalosporin Intermediates Sales 2017-2022 (K Units)
Figure 35. Europe Cephalosporin Intermediates Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Cephalosporin Intermediates Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Cephalosporin Intermediates Revenue 2017-2022 ($ Millions)
Figure 38. Americas Cephalosporin Intermediates Sales Market Share by Country in 2021
Figure 39. Americas Cephalosporin Intermediates Revenue Market Share by Country in 2021
Figure 40. United States Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Cephalosporin Intermediates Sales Market Share by Region in 2021
Figure 45. APAC Cephalosporin Intermediates Revenue Market Share by Regions in 2021
Figure 46. China Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Cephalosporin Intermediates Sales Market Share by Country in 2021
Figure 53. Europe Cephalosporin Intermediates Revenue Market Share by Country in 2021
Figure 54. Germany Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Cephalosporin Intermediates Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Cephalosporin Intermediates Revenue Market Share by Country in 2021
Figure 61. Egypt Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Cephalosporin Intermediates Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Cephalosporin Intermediates in 2021
Figure 67. Manufacturing Process Analysis of Cephalosporin Intermediates
Figure 68. Industry Chain Structure of Cephalosporin Intermediates
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets